Tuberkuloz ve Toraks-Tuberculosis and Thorax

Scope & Guideline

Bridging research and practice in respiratory medicine.

Introduction

Explore the comprehensive scope of Tuberkuloz ve Toraks-Tuberculosis and Thorax through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Tuberkuloz ve Toraks-Tuberculosis and Thorax in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN0494-1373
PublisherTURKISH ASSOC TUBERCULOSIS & THORAX
Support Open AccessNo
CountryTurkey
TypeJournal
Convergefrom 2003 to 2024
AbbreviationTUBERK TORAK / Tuberk. Toraks
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressC/O AKIN KAYA MD, PROFESSOR, DEPT CHEST DISEASES, FAC MEDICINE, ANKARA 06100, Turkiye

Aims and Scopes

The journal 'Tuberkuloz ve Toraks-Tuberculosis and Thorax' focuses on a broad spectrum of respiratory diseases, with a particular emphasis on tuberculosis and related pulmonary conditions. Its aims include advancing knowledge in the field through clinical studies, reviews, and innovative research methodologies.
  1. Tuberculosis Research:
    A core focus of the journal is on tuberculosis, including its diagnosis, treatment, and complications. Studies often explore novel therapeutic approaches and public health strategies to combat TB.
  2. Respiratory Disease Management:
    The journal covers various aspects of managing chronic respiratory diseases such as asthma, COPD, and interstitial lung diseases, emphasizing clinical outcomes and patient management strategies.
  3. Pulmonary Pathophysiology and Diagnostics:
    Research on the underlying pathophysiological mechanisms of respiratory diseases, alongside advances in diagnostic techniques like imaging and biomarkers, is a consistent theme.
  4. COVID-19 Impact and Related Respiratory Conditions:
    Given the recent pandemic, there is a significant focus on the effects of COVID-19 on respiratory health, including long-term sequelae and management strategies.
  5. Innovative Therapeutics and Technologies:
    The journal promotes studies on the latest therapeutic innovations, including biologics and personalized medicine, particularly in the treatment of severe asthma and other chronic conditions.
Recent years have seen the emergence of new themes within the journal, reflecting current trends in respiratory medicine and public health. These topics highlight the evolving landscape of research priorities.
  1. Long COVID and Post-COVID Conditions:
    There is a growing body of literature addressing the long-term effects of COVID-19, including post-COVID syndrome, which is crucial for understanding and managing ongoing respiratory issues.
  2. Telemedicine and Remote Patient Monitoring:
    The shift towards telemedicine, particularly during and after the pandemic, has led to increased research on its effectiveness in managing respiratory diseases and enhancing patient care.
  3. Biologics and Targeted Therapies:
    Research on the use of biologics for severe asthma and other conditions is on the rise, reflecting a trend towards personalized medicine and targeted treatment approaches.
  4. Impact of Environmental Factors on Respiratory Health:
    Emerging studies explore how environmental factors, such as air pollution and climate change, affect respiratory health, indicating a significant shift towards public health and environmental health intersections.
  5. Artificial Intelligence in Pulmonology:
    The application of AI and machine learning in diagnosing and managing respiratory diseases is gaining traction, with studies focusing on its potential to enhance diagnostic accuracy and treatment outcomes.

Declining or Waning

While the journal maintains a diverse range of topics, certain themes have seen a decline in recent publications. These areas may reflect shifting research priorities or reduced interest in specific methodologies or conditions.
  1. Traditional Epidemiological Studies:
    There appears to be a decline in traditional epidemiological studies focused solely on the prevalence of respiratory diseases, as newer methodologies and technologies gain traction.
  2. Basic Science Research on Respiratory Diseases:
    Research that emphasizes basic science or laboratory studies without direct clinical application has become less prominent, as the journal increasingly prioritizes studies with immediate clinical relevance.
  3. Niche Respiratory Conditions:
    Coverage of less common respiratory conditions, such as rare lung diseases, has diminished in favor of more prevalent conditions and those with greater public health impact.

Similar Journals

RESPIRATORY MEDICINE

Advancing the Frontiers of Pulmonary Health
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

Minerva Respiratory Medicine

Fostering collaboration for improved respiratory outcomes.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

REVUE DES MALADIES RESPIRATOIRES

Advancing knowledge in pulmonary health.
Publisher: MASSON EDITEURISSN: 0761-8425Frequency: 10 issues/year

REVUE DES MALADIES RESPIRATOIRES is a distinguished journal published by MASSON EDITEUR, focusing on the vital field of pulmonary and respiratory medicine. Established in 1984, this journal has become a prominent platform for sharing innovative research and clinical findings, reflecting an impressive array of studies that contribute to our understanding of respiratory diseases. With its ISSN 0761-8425 and E-ISSN 1776-2588, it facilitates access to scholarly work within the medical community, although it currently operates under a subscription model rather than Open Access. As indicated by its quartile ranking of Q4 in 2023 within its category and a Scopus rank of #128/155, REVUE DES MALADIES RESPIRATOIRES serves as an essential resource for researchers, professionals, and students aiming to stay informed about advancements in respiratory health. This journal plays a crucial role in fostering discussions that drive innovation and best practices in the treatment and understanding of respiratory conditions.

Tuberculosis and Respiratory Diseases

Fostering innovation in pulmonary medicine.
Publisher: THE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASESISSN: 1738-3536Frequency: 4 issues/year

Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.

Annals of Thoracic Medicine

Connecting researchers and practitioners in thoracic health.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1817-1737Frequency: 4 issues/year

Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Elevating critical care standards with innovative insights.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Egyptian Journal of Bronchology

Unveiling breakthroughs in bronchology for global impact.
Publisher: SPRINGERISSN: 1687-8426Frequency: 4 issues/year

Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.

Egyptian Journal of Chest Diseases and Tuberculosis

Transforming knowledge into practice for better respiratory care.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0422-7638Frequency: 4 issues/year

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.

Lancet Respiratory Medicine

Transforming respiratory health through cutting-edge research.
Publisher: ELSEVIER SCI LTDISSN: 2213-2600Frequency: 12 issues/year

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.

Lung India

Pioneering the future of respiratory research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.